Press Releases

Press Releases

Medical Prognosis Institute A/S announced today that Oncology Venture, the drug development arm of MPI, and Lantern Pharma, Inc. (Dallas, TX, US) have entered into a definitive agreement and partnership to clinically advance Irofulven for the treatment of metastatic castration resistant prostrate cancer (mCRPC) by utilizing a highly predictive biomarker…

Press Releases

Moberg Pharma AB today announced that the European Patent Office has issued patent no. 2,777,689 for an improved formulation of Moberg Pharma’s market-leading OTC product for the treatment of fungal nails, sold in the U.S. under the Kerasal Nail® brand. The patent expires in 2034.The new European patent comprises composition…

Press Releases

Zosano Pharma Corporation, a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver therapeutics conveniently through the skin for the treatment of a variety of indications, today announced the election of Joseph "Jay" P. Hagan to its Board of Directors, effective May 22, 2015.…

Press Releases

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced that it will be presenting at several upcoming investor and scientific conferences.     Event: Fourth Annual SeeThru Equity Microcap Investor Conference   Presentation with Audio Webcast Date: Thursday,…

Press Releases

NeuroVive Pharmaceutical AB, the mitochondrial medicine company, announces that NeuroVive Pharmaceutical Asia group has signed a collaboration agreement with Sanofi’s local affiliate for the development and commercialization of CicloMulsion® in South Korea. Under the agreement NeuroVive Asia will get an upfront payment, a conditional milestone payment and royalty on potential…

Press Releases

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the appointment of Gerald Quirk as General Counsel and Executive Vice President, Business Operations. Mr. Quirk brings to Tokai more than twenty years of experience advancing the legal and business…

Press Releases

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the Jefferies 2015 Healthcare Conference on Tuesday, June 2, 2015, at 1:30 p.m. Eastern Time in New York City. A…

Press Releases

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto™ Respimat® (tiotropium bromide and olodaterol) Inhalation Spray. It has been approved as a long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Stiolto™ Respimat®…

Press Releases

InMed Pharmaceuticals Inc., announced today that it has filed a provisional patent application with the United States Patent and Trademark Office ("USPTO") relating to the treatment of Epidermolysis Bullosa Simplex (EBS) using novel formulations of natural cannabinoid compounds developed by InMed. Dr. Sazzad Hossain, InMed Pharmaceuticals' Chief Scientific Officer, commented,…

Press Releases

NeuroVive Pharmaceutical AB , the mitochondrial medicine company, expects to announce the topline result of the phase III CIRCUS study of CicloMulsion® in patients with a specific type of heart attack known as ST-segment elevation acute myocardial infarction (STEMI) this quarter due to an earlier than previously expected database lock.…